Aug 29 |
The most expensive drugs in the US
|
Aug 28 |
BioMarin Pharmaceutical to lay off 225 employees
|
Aug 28 |
Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"
|
Aug 28 |
Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
|
Aug 23 |
Is the Options Market Predicting a Spike in BioMarin (BMRN) Stock?
|
Aug 21 |
BioMarin: Voxzogo Sales Surge Isn't Only Driving Force In 2024
|
Aug 21 |
BioMarin appoints new business chief and R&D head
|
Aug 21 |
BioMarin Announces New R&D and Business Development Leadership
|
Aug 21 |
BioMarin taps Amgen, Roche vets in executive reshuffle
|
Aug 20 |
BioMarin Pharmaceutical upgraded to Outperform ahead of investor day
|